Clinical Trials

Contact Us

NRG BR008 (XRT at MBMC Only)

Study Number: NRG BR008 (XRT at MBMC Only)
Please Note:

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.

Available Sites
  • Missouri Baptist Medical Center
  • Missouri Baptist Sullivan Hospital
  • Missouri Baptist Medical Center
  • Sainte Genevieve County Memorial Hospital
  • Parkland Health Center - Farmington
Contact Person(s)
  • Monica Russo 314-996-5868

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.